Core Insights - HOPE Therapeutics has opened a new clinic in Palm Beach, Florida, focusing on treating Depression and PTSD using interventional psychiatry methods, including ketamine and other neuroplastic drugs, TMS, and hyperbaric oxygen therapy combined with psychotherapy [1][5] Company Overview - HOPE Therapeutics is a subsidiary of NRx Pharmaceuticals, aiming to establish a network of interventional psychiatry clinics that provide advanced treatments for suicidal depression and related disorders [5] - The company is the first in Florida to offer the AMPA One Day (ONE-D) treatment, which combines TMS, physician-prescribed D-cycloserine, and lisdexamfetamine for rapid remission from treatment-resistant depression [5] Treatment Efficacy - Peer-reviewed studies indicate an 87% clinical response rate for patients with treatment-resistant depression using a short-term treatment protocol [2] - Pilot programs incorporating hyperbaric oxygen therapy have shown a 90% rate of return to full function in patients with depression and PTSD [2] - TMS has demonstrated potential benefits in improving memory and cognition in patients with Alzheimer's disease and traumatic brain injury [2] Historical Context - Traditional antidepressants have a success rate of only 37% and are associated with various negative side effects, while severe cases previously relied on electroshock therapy [3] - The introduction of modern neuroplastic therapies offers a promising alternative with the potential for rapid recovery without the need for daily medications [3]